SMIM22 and breast cancer: Polycarpou-Schwarz et al. found that in hormone-dependent BC, CASIMO1 interact with the oncogene SQLE, altering the activity or conformation of SQLE to activate the ERK/MAPK pathway [22] (Fig. 1).